Sign In
Section Navigation
Common TitleHPTN 084-1 (Adolescents-LIFT Study)
Official Title Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV among Adolescent Females – A Sub-study of HPTN 084
Purpose / DescriptionTo establish the minimum safety, tolerability and acceptability data needed to support the use of cabotegravir long-acting injection (CAB LA) in an adolescent population, potentially transforming the field of HIV prevention for young people.
Phase Phase IIB
Treatments
Cabotegravir

Cabotegravir

Tradename:ApretudeOther Names:CAB-LA, Injectable cabotegravirClass:Integrase Strand Transfer Inhibitors (INSTI)
Funding
IndustryViiV Healthcare
Non-IndustryNational Institute of Allergy and Infectious Diseases

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.